Full U.S. Launch of New nanoLOCK Surface Technology from Titan Spine
Titan Spine commenced full U.S. distribution of Endoskeleton® titanium implants featuring new proprietary nanoLOCK® surface technology. Since introduction, Titan Spine has sold nanoLOCK implants to 14 hospitals in 8 states.
Within 2016, CMS created a new technology ICD-10 code for a nanotextured surface on an interbody fusion device. Titan Spine’s nanoLOCK surface technology now has access to use this code. Further, all Endoskeleton devices are covered by a risk share warranty which has been amended to provide a free replacement if any Endoskeleton interbody fusion device delaminates or generates particulate debris during implantation.
Sources: Titan Spine LLC; ORTHOWORLD Inc.